Key Takeaways Labcorp targets growth through specialty testing in oncology, neurology and women's health. LH expanded with key acquisitions and partnerships to boost its national and clinical presence. Labcorp's solid balance sheet supports dividends and buybacks despite rising competitive pressure.Labcorp Holdings Inc. (LH) , or Labcorp’s strong focus on key areas such as oncology, women’s health, autoimmune disease and neurology is poised to help it grow in the upcoming quarters. The company maintains a ...

Key Takeaways Labcorp expanded its precision oncology portfolio with new solid tumor and hematologic cancer tests. LH added HRD testing and HER2 subtyping, and launched the Rapid AML Panel for advanced cancer profiling. Labcorp launched a global digital pathology platform to boost companion diagnostic development efforts.Labcorp (LH) recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid tumor and hematologic malignancies and enhanced biopharma so ...

LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University’s College of Health Solutions and Labcorp, a global leader of innovative and comprehensive laboratory services, to launch a Master of Science in Cytology. ASU’s online graduate program addresses the severe shortage of cytotechnologists—specialists essential to cancer detection and diagnostics. With only 19 training pr ...

New test offerings target solid tumors and hematologic malignanciesEnhanced biopharma services support accelerated clinical trials and companion diagnostic developmentBURLINGTON, N.C., May 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed to accelerate ...

It has been about a month since the last earnings report for Labcorp (LH) . Shares have added about 2.5% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Labcorp due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are t ...

Financial Data and Key Metrics Changes - LabCorp reported exceptional results in 2024, with strong momentum heading into 2025, indicating a positive outlook for financial performance [4] - At least 91% of shares voted in favor of the nonbinding advisory approval of the company's compensation for named executive officers, reflecting shareholder confidence [30] - The approval rate for the company's 2025 omnibus incentive plan was at least 94%, and for the employee stock purchase plan, it was at least 99% [30] Business Line Data and Key Metrics Changes - The diagnostics and biopharma laboratory services businesses made meaningful advances through organic growth and transformative acquisitions, contributing to the overall success of LabCorp [4] Market Data and Key Metrics Changes - No specific market data or key metrics changes were provided in the meeting [0] Company Strategy and Development Direction - LabCorp is focused on improving health and lives while generating attractive returns for shareholders, positioning itself well for future growth [4] - The company emphasizes ethical and regulatory responsibilities in its biopharma laboratory services, particularly regarding animal welfare and research integrity [35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in LabCorp's positioning for continued success in 2025, highlighting the importance of their strategic initiatives [4] - The company is committed to high standards of animal care and welfare, which is fundamental to sound scientific research [35] Other Important Information - The meeting included the election of directors, approval of executive compensation, and ratification of the independent registered public accounting firm for 2025, all of which passed with significant support from shareholders [30] Q&A Session Summary Question: What specific measures is LabCorp taking to mitigate biosafety and public health risks associated with research animals? - LabCorp takes its ethical and regulatory responsibilities seriously, ensuring the health and wellness of research animals, which is fundamental to scientific research [35] - The company has a dedicated global team to establish high standards of animal care and welfare, proactively identifying and mitigating risks [36]

BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmac ...

Labcorp Holdings (LH) Q1 2025 Earnings Call April 29, 2025 02:09 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Q1 twenty twenty five LabCorp Holdings Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your ques ...

Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company's control, including without limitation: (i) the effect of the holding company reorganization on the company's business generally; (ii) the failure to receive tax-free treatment with respect to the spin-off of the company's Clinical Development and Commercialization Services business, now Fortrea Holdings Inc. for U.S. federal income purposes; (iii) the impact of spin-off rela ...